About
HTL is a manufacturer and research & development of Hyaluronan and other biological polymers by bacterial fermentation. HTL SAS was created in 1992 and is specialized in the manufacture, purification and research and development of Hyaluronan (HA). Today it has diversified and produces other biological polymers (see new products) for the pharmaceutical and medical fields.
Position in the VCSift Database
- • 4,609 investors in VCSift focus on the biotech sector.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- biotech
- Location
- Javené, France
Contact Information
linkedin.com/in/••••••••
Find more investors like HTL
Search Investors